Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Virax Biolabs Group Limited - Ordinary Shares (NQ:VRAX)

0.8825 -0.0775 (-8.07%)
Streaming Delayed Price Updated: 3:48 PM EDT, Jun 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 72,869
Open 0.9600
Bid (Size) 0.8800 (57)
Ask (Size) 0.8815 (270)
Prev. Close 0.9600
Today's Range 0.8505 - 0.9600
52wk Range 0.8200 - 9.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga

Performance

YTD
-60.1%
-60.1%
1 Month
-16.4%
-16.4%
3 Month
-31.6%
-31.6%
6 Month
-45.2%
-45.2%
1 Year
-47.5%
-47.5%

More News

Read More
Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating
Via Benzinga
Exposures COVID-19
EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency
Via Benzinga
How Is The Market Feeling About Virax Biolabs Group?
Via Benzinga
Why Cosmos Health Stock Is Moving Higher Wednesday
Via Benzinga
How Is The Market Feeling About Virax Biolabs Group?
Via Benzinga
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
Nasdaq Down 2%; US Crude Stocks Increase
Via Benzinga
Gold Moves Lower; AT&T Earnings Top Views
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss
Via Benzinga
Topics Stocks
Exposures US Equities
EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland
Via Benzinga
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank?
Via Benzinga
Nasdaq Down Over 1%; Foot Locker Shares Tumble After Q2 Results
Via Benzinga
What's Going On With Virax Biolabs Stock Wednesday
Via Benzinga
Topics Supply Chain
Exposures Supply Chain
US Stocks Mixed; JM Smucker Slashes Annual Guidance
Via Benzinga
EXCLUSIVE: Virax Biolabs Inks Distribution Pact For Mpox Diagnostic Kits In Europe And Middle East
Via Benzinga
Virax Biolabs Announces Stock Offering: What To Know
Via Benzinga
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Nasdaq Surges 150 Points; Sonder Holdings Shares Surge
Via Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Crude Oil Down 2%; Alzamend Neuro Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Virax Biolabs Shares Climb With Mpox Cases: What To Know
Via Benzinga

Frequently Asked Questions

Is Virax Biolabs Group Limited - Ordinary Shares publicly traded?
Yes, Virax Biolabs Group Limited - Ordinary Shares is publicly traded.
What exchange does Virax Biolabs Group Limited - Ordinary Shares trade on?
Virax Biolabs Group Limited - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Virax Biolabs Group Limited - Ordinary Shares?
The ticker symbol for Virax Biolabs Group Limited - Ordinary Shares is VRAX on the Nasdaq Stock Market
What is the current price of Virax Biolabs Group Limited - Ordinary Shares?
The current price of Virax Biolabs Group Limited - Ordinary Shares is 0.8825
When was Virax Biolabs Group Limited - Ordinary Shares last traded?
The last trade of Virax Biolabs Group Limited - Ordinary Shares was at 06/13/25 03:48 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.